Dananberg Jamie
CHIEF MEDICAL OFFICER
Dananberg Jamie has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Mar 4, 2026.
On the most recent filing, Dananberg Jamie is listed as CHIEF MEDICAL OFFICER at Annexon, Inc. Inside the rolling window, Dananberg Jamie reported no open-market purchases and 2 open-market sales totaling $59K in ANNX. The largest disclosed transaction in the window is a sale of 5,820 ANNX shares on Mar 2, 2026, worth $32K.
Companies traded
Other insiders at ANNX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$59K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Dananberg Jamie made?
Dananberg Jamie has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Dananberg Jamie trade?
Dananberg Jamie has filed SEC Form 4 disclosures for 1 company, including ANNX.
When was Dananberg Jamie's most recent SEC Form 4 filing?
Dananberg Jamie's most recent SEC Form 4 filing on Tracefour is dated Mar 4, 2026.
What is Dananberg Jamie's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Dananberg Jamie is listed as CHIEF MEDICAL OFFICER.
What is Dananberg Jamie's total buy and sell value in the current window?
Inside the rolling retention window, Dananberg Jamie bought $0 and sold $59K based on SEC Form 4 filings.
What was Dananberg Jamie's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,820 ANNX shares on 2026-03-02, worth $32K, per SEC Form 4 filings.